LLY vs VTRS
By Alex · Tickerpine
Eli Lilly and Company vs Viatris Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | VTRS |
|---|---|---|
| Price | $1,443.50 | $20.82 |
| Market cap | $1.29T | $23.87B |
| P/E ratio | 46.9 | — |
| ROE | 86.02% | -4.21% |
| Profit margin | 31.90% | -4.13% |
| Revenue growth | 38.60% | -0.30% |
| Dividend yield | 0.48% | 2.30% |
| Beta | 0.39 | 0.87 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs VTRS in plain English
- LLY is the bigger company — about 53.9× the market cap of VTRS.
- LLY earns a higher return on equity (86% vs -4%).
- LLY is growing revenue faster (39% vs -0%).
- VTRS has the higher dividend yield (2.30% vs 0.48%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
VTRS return calculator
See what $1,000 in Viatris Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.